Home » Oral Thin Film Drugs Market

Oral Thin Film Drugs Market By Product (Sublingual Film, Fully Dissolving Buccal Film), By Indication (Migraine, Schizophrenia, Alzheimer’s Disease, Nausea & Vomiting, Opioid Dependence Tests) – Growth, Share, Opportunities & Competitive Analysis, 2017 – 2025

Price: $4999

Published: | Report ID: 8174 | Report Format : PDF

Market Insights

Thin-film drugs have been identified as an alternative to conventional dosage forms. Oral thin films are thin, flexible films of drug delivery that dissolve in the oral mucosa, resulting in a rapid onset of action and improved bioavailability for drugs. The thin oral film is mostly used for geriatric, pediatric, and bedridden patients who are unable to take the solid form of the drug. Rising demand for an efficient drug delivery route and its acceptability in the region would further drive the thin film drug manufacturing market in the future.

The report titled “Global Oral Thin Film Drugs Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall oral thin film drug market, along with the market size and estimates for the duration of 2017–2025. The research study covers an in-depth analysis of market segments based on product type and different geographical regions.

The report also includes sections on the competitive profiling of the leading players in the global oral thin film drugs market, attractive investment propositions, and market positioning of key manufacturers to assist strategic decision-makers.

Geographically, the global oral thin film drugs market is studied for the following regional markets:

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • rest of Latin America

Middle East and Africa

  • GCC
  • Rest of the Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period of 2015–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global oral thin film drug market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the global oral thin film drug market’s competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global oral thin film drug market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global oral thin film drugs market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on the type of product, the oral thin film drug market is segmented into:

  • Thin Film Oral
  • Sublingual Film
  • fully dissolving buccal film

Scientists throughout the pharmaceutical industry have been trying to explore thin films as novel drug delivery tools. Thin-film drugs have been identified as an alternative to conventional dosage forms. Based on the type of product, the oral thin film drug market is segmented into sublingual film and fully dissolving buccal film.

The sublingual film held the largest share in the oral thin film drug market due to the ease of consumption and its effectiveness as it provides rapid dissolution of the drug without the intake of water and rapid onset of action when delivered orally. There has been a good acceptance of oral drugs as it rules out the problem of dysphagia, a common problem due to difficulty swallowing in people of all ages, and hence it is anticipated to exhibit a tremendous growth rate during the forecast period of 2017 to 2025.

Based on the type of indication, the oral thin film drug market is segmented into:

  • Migraine
  • Schizophrenia
  • Alzheimer’s Disease
  • Nausea and vomiting
  • Opioid Dependence
  • Others

The pharmaceutical industry is focusing its interest on shortening drug development timelines and developing efficient drug delivery platforms. Moreover, there is an increasing demand for efficient drug delivery techniques as well as convenience in the transportation of the drug, which has fueled the oral thin film drug market in the recent past. In terms of indication, the oral thin film drugs market is segmented as migraine, schizophrenia, Alzheimer’s disease, eye diseases, nausea and vomiting, opioid dependence, and others. Thin-film oral drugs make it easy to swallow drugs without water, especially for pediatric, geriatric, and neurodegenerative patients, where conventional drug delivery is difficult. Hence, Alzheimer’s disease, migraine, and opioid dependence would lead the market in the future.

For the purpose of this study, the global oral thin film drugs market is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

For the purpose of this study, the global oral thin film drugs market is segmented into six regional markets: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In the base year 2016, North America was observed as the largest regional segment in the oral thin film drugs market. The U.S. led the North American oral thin film drug market, accounting for more than 80% of the market share due to advanced technologies used in pharmaceutical research and development for the discovery of novel drug delivery techniques. Moreover, the rising demand for an efficient drug delivery route and its acceptability in the region would further drive the oral thin film drug market in the future. However, favorable regulation, growing awareness among the masses, and the launch of novel products would make the Asia Pacific the fastest-growing geographical region during the forecast period. Moreover, rising target populations in the region and the major contributions of India and China to pharmaceutical development would further benefit the oral thin film drug market in the region.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Oral Thin Film Drugs Portraiture
2.2 Oral Thin Film Drugs Market, by Product Type, 2016 (US$ Mn)
2.3 Oral Thin Film Drugs Market, by Indication Type, 2016 (US$ Mn)
2.4 Oral Thin Film Drugs Market, by Geography, 2016 (Value %)

Chapter 3 Global Oral Thin Film Drugs Market Analysis
3.1 Global Oral Thin Film Drugs Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Mergers, Acquisition and Business Strategies
3.4 Attractive Investment Proposition
3.5 Competitive Analysis: Global Oral Thin Film Drugs Market, 2016 (Value %)

Chapter 4 Global Oral Thin Film Drugs Market Analysis, By Product Type
4.1 Overview
4.1.1 Market Share Analysis of Oral Thin Film Drugs Market, by Product Type, 2016
4.2 Sublingual Film
4.3 Fully Dissolving Buccal Film

Chapter 5 Global Oral Thin Film Drugs Market Analysis, By Indication Type
5.1 Overview
5.1.1 Market Attractive Proposition of Oral Thin Film Drugs Market, by Indication Type, 2016
5.2 Migraine
5.3 Schizophrenia
5.4 Alzheimer’s Disease
5.5 Nausea & Vomiting
5.6 Opioid Dependence Tests
5.7 Other Indication

Chapter 6 Global Oral Thin Film Drugs Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Oral Thin Film Drugs Market, by Product Type, 2015-2025 (US$ Mn)
6.2.2 North America Oral Thin Film Drugs Market, by Indication Type, 2015-2025 (US$ Mn)
6.2.3 North America Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Oral Thin Film Drugs Market, by Product Type, 2015-2025 (US$ Mn)
6.3.2 Europe Oral Thin Film Drugs Market, by Indication Type, 2015-2025 (US$ Mn)
6.3.3 Europe Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
6.4.1 Asia Pacific Oral Thin Film Drugs Market, by Product Type, 2015-2025 (US$ Mn)
6.4.2 Asia Pacific Oral Thin Film Drugs Market, by Indication Type, 2015-2025 (US$ Mn)
6.4.3 Asia – Pacific Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Oral Thin Film Drugs Market, by Product Type, 2015-2025 (US$ Mn)
6.5.2 Latin America Oral Thin Film Drugs Market, by Indication Type, 2015-2025 (US$ Mn)
6.5.3 Latin America Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.6 Middle East and Africa (GCC and Rest of MEA)
6.6.1 Middle East and Africa Oral Thin Film Drugs Market, by Product Type, 2015-2025 (US$ Mn)
6.6.2 Middle East and Africa Oral Thin Film Drugs Market, by Indication Type, 2015-2025 (US$ Mn)
6.6.3 Middle East and Africa Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)

Chapter 7 Company Profiles
7.1 MONOSOL RX
7.2 TESA LABTEC GMBH
7.3 PFIZER, INC
7.4 NOVARTIS AG
7.5 WOLTERS KLUWER
7.6 SOLVAY
7.7 ALLERGAN PLC
7.8 SUMITOMO DAINIPPON PHARMA CO. LTD
7.9 INTELGENX CORP
7.10 TRANSITION THERAPEUTICS, INC.

List of Figures

FIG. 1 Oral Thin Film Drugs Market: Research Methodology
FIG. 2 Oral Thin Film Drugs Market, by Product Type, 2016 (US$ Mn)
FIG. 3 Oral Thin Film Drugs Market, by Indication Type, 2016 (US$ Mn)
FIG. 4 Oral Thin Film Drugs Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition
FIG. 6 Competitive Analysis: Global Oral Thin Film Drugs Market, 2016 (Value %)
FIG. 7 Global Sublingual Film Market(US$ Mn), 2015-2025
FIG. 8 Global Fully Dissolving Buccal Film Market(US$ Mn), 2015-2025
FIG. 9 Global Oral Thin Films Drugs for Migraine Market(US$ Mn), 2015-2025
FIG. 10 Global Oral Thin Films Drugs for Schizophrenia Market(US$ Mn), 2015-2025
FIG. 11 Global Oral Thin Films Drugs for Alzheimer’s Disease Market (US$ Mn), 2015-2025
FIG. 12 Global Oral Thin Films Drugs for Nausea & Vomiting Market (US$ Mn), 2015-2025
FIG. 13 Global Oral Thin Films Drugs for Opioid Dependence Market (US$ Mn), 2015-2025
FIG. 14 Global Oral Thin Films Drugs for Other Indication Market(US$ Mn), 2015-2025

List of Tables

TABLE 1 Global Oral Thin Film Drugs Market, By Product Type (US$ Mn), 2015– 2025 (Value)
TABLE 1 Global Oral Thin Film Drugs Market, By Indication Type (US$ Mn), 2015– 2025 (Value)
TABLE 2 Global Oral Thin Film Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 3 North America Oral Thin Film Drugs Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 4 North America Biological Safety Tests Market, by Indication Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Oral Thin Film Drugs Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Oral Thin Film Drugs Market, by Indication Type, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Asia Pacific Oral Thin Film Drugs Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Oral Thin Film Drugs Market, by Indication Type, 2015 – 2025 (US$ Mn)
TABLE 11 Asia – Pacific Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Latin America Oral Thin Film Drugs Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 13 Latin America Oral Thin Film Drugs Market, by Indication Type, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Middle East and Africa Oral Thin Film Drugs Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 16 Middle East and Africa Oral Thin Film Drugs Market, by Indication Type, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East and Africa Oral Thin Film Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 18 MONOSOL RX: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 19 TESA LABTEC GMBH: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 20 PFIZER, INC: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 21 NOVARTIS AG: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 22 WOLTERS KLUWER: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 23 SOLVAY: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 24 ALLERGAN PLC: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 25 SUMITOMO DAINIPPON PHARMA CO. LTD: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 26 INTELGENX CORP: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 27 TRANSITION THERAPEUTICS, INC.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)

Frequently Asked Question:

What is the size of Oral Thin Film Drugs Market?

The market for Oral Thin Film Drugs Market is expected to reach USD$ XX Bn in 2025.

What is the Oral Thin Film Drugs Market CAGR?

The Oral Thin Film Drugs Market is expected to see significant CAGR growth over the coming years, at 8.9%.

What is the Forecast period considered for Oral Thin Film Drugs Market?

The report is forecasted to 2017-2025.

What is the base year considered for Oral Thin Film Drugs Market?

The base year of this report is 2016.

Who are the major players in this market?

MONOSOL RX, TESA LABTEC GMBH, PFIZER, INC, NOVARTIS AG, WOLTERS KLUWER, SOLVAY, ALLERGAN PLC. are some of the major players in the global market.

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market

Published:
Report ID: 33712

Tracheitis Treatment Market

Published:
Report ID: 33694

Neuralgia Treatment Market

Published:
Report ID: 33681

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

Pediatric Bladder Treatment Market

Published:
Report ID: 33540

Neurotrophic Keratitis Treatment Market

Published:
Report ID: 33425

Precision Medicine Market

Published:
Report ID: 11123

Eosinophilic Pneumonia Treatment Market

Published:
Report ID: 5486

Myelodysplastic Syndrome Market

Published:
Report ID: 32821

US Retail Pharmacy Market

Published:
Report ID: 32801

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN